Concerto Biosciences

In its Phase 1b trial, our 3-strain live biotherapeutic ENS-002 showed early signs of benefit for people with eczema and no drug-related adverse events. This isn’t an antibiotic or an immunosuppressant. It’s microbial medicine. concertobio.com/press/concerto…

Using kChip, we generated & profiled millions of microbial communities, transforming complexity into a searchable design space. That search yielded ENS-002, a 3-strain consortium that targets S. aureus to treat atopic dermatitis. Read the discovery story: biorxiv.org/content/10.648…

Concerto has entered a strategic collaboration with Sacco System to advance next-gen microbial ingredient discovery. “We strongly believe that kChip technology is the perfect match for our needs." -Federica Volontè, R&D Biology Manager, Sacco. Read on: concertobio.com/press/concerto…

With over 33 million datapoints, Concerto's Skin Universe Project offers the most detailed view yet of how skin microbes influence one another—and how to harness them for therapeutics and skincare solutions. Read on. concertobio.com/press/concerto…

Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting. The study site is in Austin, TX. If you are interested in learning more about it, you can connect with the research site here: getinastudy.com/study/atopic-d….

Women in Tech: Meet @cheri_ackerman, Co-Founder and CEO of @ConcertoBio! Let’s celebrate Cheri’s passion for science and #leadership in tech as she sets a powerful example for women aspiring to make their mark in the industry! #WomeninTech #MedTech #ScientificAdvancement

Microbes, specifically microbial products that aren't designed to kill microbes, are incredibly underrated. Episode 19 of S³ features @ConcertoBio who are leveling up humanity's microbes.

Sandbox alumni team, @concertobio, is leveraging the untapped potential of microbes, "the first intelligent problem solvers on earth." Learn more about problems they're solving with this novel idea: ow.ly/FW5z50Qf668 #mitsandbox #innovation #entrepreneurship #startups

We want every microbial product that should exist to exist—and that begins with sharing our outlook on the untapped potential of the microbial world. Here we tell the story of Concerto. Thanks to mastermind-behind-the-lens @jasonjoyride (@s3news_) and sponsor @pillar_vc.

Concerto's 4th retreat: Outdoor teaming (great for our microbiomes), contemplations on microbial ecology (and how we’ll solve it), musical Jeopardy (a grand piano on site), and our cooking competition (combinatorial ingredients!). We return with minds—and microbiomes—restored.

Signal was excited to host @cheri_ackerman to discuss her experience starting @concertobio out of her academic work. "Go make it happen."

Discover the microbe world within us! 🔬🦠 w/ @cheri_ackerman / @ConcertoBio’s kChip, we explore complex microbial interactions and their work on an eczema treatment. Tune in: 📺: youtube.com/watch?v=crI9ty… 🎧: buzzsprout.com/1169378/129888… 📖: toughtechtoday.com/orchestrating-… #toughtechtuesday

@HeidiArjes from @ConcertoBio will continue the "New Methods in Microbiology" session with a presentation on "Discovery of an S. aureus-pacifying microbial ensemble via massively parallel measurement of millions of microbial interactions"

Concerto CSO @jaredscottkehe will present the liberation of the microbe—no longer just a therapeutic target, but now a therapeutic solution. He’ll show how Concerto’s massive microbial interaction dataset is propelling a new era of applied microbiology. Register below!

The Concertians are explorers, impassioned by the secrets of the vast, invisible microbial world. We watch millions of dropletized microbial communities, each its own tiny world of possibilities, just as astronauts watch the stars and planets—with curiosity, hope, and big dreams.

Of microbes and music! Certain note combinations sound discordant until they’re woven into the larger score; the same goes for how microbes interact within their larger communities. Concerto CSO @jaredscottkehe explains in this profile from @MIT_alumni. alum.mit.edu/slice/overturn…

We're celebrating recent funding wins for @ConcertoBio, @AnthroEnergy, @NitricityInc, & AeroShield Materials. Earlier this year, total follow-on funding for #ActivateFellows reached $1B. More from on what that number means for our fellows and ecosystem: activatefello.ws/3AeK8lb

What a title! 🎹 @endpts and @ky_lahucik capture our vision, energy, and passion in this profile of Concerto’s Series A fundraise. endpts.com/rulebook-of-mi…

🎺A fanfare for Concerto’s Series A! It heralds our reunion with microbes. It calls us to explore, compose, collaborate. It reverberates toward a future where microbes aren’t problems but solutions. Cheers to the era of microbial ecology-inspired products. businesswire.com/news/home/2022…

HAPPENING NOW: Concerto Biosciences CEO @cheri_ackerman presents how we discovered Ensemble No.2, a new microbial treatment for eczema—and why we owe it to eczema patients to make skin microbiome research comprehensive and rigorous. See you there!